The mechanism of γ-Secretase dysfunction in familial Alzheimer disease

Annaert, 2001, Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins, Neuron, 32, 579, 10.1016/S0896-6273(01)00512-8

Annaert, 1999, Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons, J Cell Biol, 147, 277, 10.1083/jcb.147.2.277

Bentahir, 2006, Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms, J Neurochem, 96, 732, 10.1111/j.1471-4159.2005.03578.x

Berezovska, 2005, Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein, J Neurosci, 25, 3009, 10.1523/JNEUROSCI.0364-05.2005

Bergmans, 2010, Gamma-secretases: from cell biology to therapeutic strategies, Lancet Neurol, 9, 215, 10.1016/S1474-4422(09)70332-1

Bezprozvanny, 2008, Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease, Trends Neurosci, 31, 454, 10.1016/j.tins.2008.06.005

Boeve, 2006, Frontotemporal dementia and parkinsonism associated with the IVS1+1G−>a mutation in progranulin: a clinicopathologic study, Brain, 129, 3103, 10.1093/brain/awl268

Borchelt, 1996, Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo, Neuron, 17, 1005, 10.1016/S0896-6273(00)80230-5

Chavez-Gutierrez, 2008, Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity, J Biol Chem, 283, 20096, 10.1074/jbc.M803040200

Czirr, 2008, Independent generation of Abeta42 and Abeta38 peptide species by gamma-secretase, J Biol Chem, 283, 17049, 10.1074/jbc.M802912200

De Strooper, 2007, Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep, 8, 141, 10.1038/sj.embor.7400897

De Strooper, 2010, Novel research horizons for presenilins and gamma-secretases in cell biology and disease, Annu Rev Cell Dev Biol, 26, 235, 10.1146/annurev-cellbio-100109-104117

De Strooper, 2010, The secretases: enzymes with therapeutic potential in Alzheimer disease, Nat Rev Neurol, 6, 99, 10.1038/nrneurol.2009.218

Duff, 1996, Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1, Nature, 383, 710, 10.1038/383710a0

Esselens, 2004, Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway, J Cell Biol, 166, 1041, 10.1083/jcb.200406060

Fernandez-Escamilla, 2004, Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins, Nat Biotechnol, 22, 1302, 10.1038/nbt1012

Fukumori, 2010, Three-amino acid spacing of presenilin endoproteolysis suggests a general stepwise cleavage of gamma-secretase-mediated intramembrane proteolysis, J Neurosci, 30, 7853, 10.1523/JNEUROSCI.1443-10.2010

Funamoto, 2004, Truncated carboxyl-terminal fragments of beta-amyloid precursor protein are processed to amyloid beta-proteins 40 and 42, Biochemistry, 43, 13532, 10.1021/bi049399k

Gillman, 2011, Discovery and evaluation of BMS-708163, a potent, selective and orally bioavailable Î3-secretase inhibitor, ACS Med Chem Lett, 1, 120, 10.1021/ml1000239

Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994

Hebert, 2004, Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity, Neurobiol Dis, 17, 260, 10.1016/j.nbd.2004.08.002

Heilig, 2010, A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of gamma-secretase activity, J Biol Chem, 285, 22350, 10.1074/jbc.M110.116962

Herreman, 2000, Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells, Nat Cell Biol, 2, 461, 10.1038/35017105

Jarrett, 1993, The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease, Biochemistry, 32, 4693, 10.1021/bi00069a001

Jarrett, 1993, Seeding ‘one-dimensional crystallization’ of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?, Cell, 73, 1055, 10.1016/0092-8674(93)90635-4

Kakuda, 2006, Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from beta-carboxyl-terminal fragment by gamma-secretase, J Biol Chem, 281, 14776, 10.1074/jbc.M513453200

Kelleher, 2010, Genetics. Gamma-secretase and human disease, Science, 330, 1055, 10.1126/science.1198668

Kim, 2007, Abeta40 inhibits amyloid deposition in vivo, J Neurosci, 27, 627, 10.1523/JNEUROSCI.4849-06.2007

Kuperstein, 2010, Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio, EMBO J, 29, 3408, 10.1038/emboj.2010.211

Lee, 2010, Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations, Cell, 141, 1146, 10.1016/j.cell.2010.05.008

Martone, 2009, Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease, J Pharmacol Exp Ther, 331, 598, 10.1124/jpet.109.152975

McGowan, 2005, Abeta42 is essential for parenchymal and vascular amyloid deposition in mice, Neuron, 47, 191, 10.1016/j.neuron.2005.06.030

Moehlmann, 2002, Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production, Proc Natl Acad Sci USA, 99, 8025, 10.1073/pnas.112686799

Murayama, 1999, Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease, Neurosci Lett, 265, 61, 10.1016/S0304-3940(99)00187-1

Murphy, 2002, FAD-linked mutations in presenilin 1 alter the length of Abeta peptides derived from betaAPP transmembrane domain mutants, Biochim Biophys Acta, 1586, 199, 10.1016/S0925-4439(01)00098-9

Oehlrich, 2011, Gamma-secretase modulators as potential disease modifying anti-alzheimer's drugs, J Med Chem, 54, 669, 10.1021/jm101168r

Page, 2008, Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation, J Biol Chem, 283, 677, 10.1074/jbc.M708754200

Pink, 2011, PSENEN and NCSTN mutations in familial hidradenitis suppurativa (acne inversa), J Invest Dermatol, 131, 1568, 10.1038/jid.2011.42

Portelius, 2010, Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease, Mol Neurodegener, 5, 2, 10.1186/1750-1326-5-2

Qi-Takahara, 2005, Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase, J Neurosci, 25, 436, 10.1523/JNEUROSCI.1575-04.2005

Quintero-Monzon, 2011, Dissociation between the processivity and total activity of gamma-secretase: implications for the mechanism of Alzheimer's disease-causing presenilin mutations, Biochemistry, 50, 9023, 10.1021/bi2007146

Saito, 2011, Potent amyloidogenicity and pathogenicity of Abeta43, Nat Neurosci, 14, 1023, 10.1038/nn.2858

Sastre, 2001, Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch, EMBO Rep, 2, 835, 10.1093/embo-reports/kve180

Sato, 2003, Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein, J Biol Chem, 278, 24294, 10.1074/jbc.M211161200

Saura, 2004, Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration, Neuron, 42, 23, 10.1016/S0896-6273(04)00182-5

Scheuner, 1996, Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat Med, 2, 864, 10.1038/nm0896-864

Shen, 2007, The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism, Proc Natl Acad Sci USA, 104, 403, 10.1073/pnas.0608332104

Shimojo, 2007, Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1, Neurosci Res, 57, 446, 10.1016/j.neures.2006.12.005

Shirotani, 2004, Identification of distinct gamma-secretase complexes with different APH-1 variants, J Biol Chem, 279, 41340, 10.1074/jbc.M405768200

Song, 1999, Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations, Proc Natl Acad Sci USA, 96, 6959, 10.1073/pnas.96.12.6959

Takami, 2009, Gamma-secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment, J Neurosci, 29, 13042, 10.1523/JNEUROSCI.2362-09.2009

Tanzi, 2005, Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008

Tolia, 2009, Structure and function of gamma-secretase, Semin Cell Dev Biol, 20, 211, 10.1016/j.semcdb.2008.10.007

Tolia, 2008, Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase, J Biol Chem, 283, 19793, 10.1074/jbc.M802461200

Wakabayashi, 2008, Presenilins: members of the {gamma}-secretase quartets, but part-time soloists too, Physiology (Bethesda), 23, 194, 10.1152/physiol.00009.2008

Wang, 2010, Gamma-secretase gene mutations in familial acne inversa, Science, 330, 1065, 10.1126/science.1196284

Wang, 2006, Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology, J Biol Chem, 281, 15330, 10.1074/jbc.M512574200

Watanabe, 2010, Functional analysis of the transmembrane domains of presenilin 1: participation of transmembrane domains 2 and 6 in the formation of initial substrate-binding site of gamma-secretase, J Biol Chem, 285, 19738, 10.1074/jbc.M110.101287

Weggen, 2001, A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity, Nature, 414, 212, 10.1038/35102591

Weidemann, 2002, A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing, Biochemistry, 41, 2825, 10.1021/bi015794o

Welander, 2009, Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains, J Neurochem, 110, 697, 10.1111/j.1471-4159.2009.06170.x

Wilson, 2004, Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons, J Cell Biol, 165, 335, 10.1083/jcb.200403061

Wiltfang, 2002, Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation, J Neurochem, 81, 481, 10.1046/j.1471-4159.2002.00818.x

Wolfe, 2007, When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep, 8, 136, 10.1038/sj.embor.7400896

Yagishita, 2008, Abeta46 is processed to Abeta40 and Abeta43, but not to Abeta42, in the low density membrane domains, J Biol Chem, 283, 733, 10.1074/jbc.M707103200

Zhang, 2010, Role of presenilins in neuronal calcium homeostasis, J Neurosci, 30, 8566, 10.1523/JNEUROSCI.1554-10.2010

Zhou, 2011, Amyloid precursor protein mutation E682K at the alternative beta-secretase cleavage beta’-site increases Abeta generation, EMBO Mol Med, 3, 291, 10.1002/emmm.201100138

De Strooper, 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, 391, 387, 10.1038/34910